August 2024

PARAMUS, N.J, Aug. 1, 2024 /PRNewswire/ — Octapharma USA, Inc. has announced the expanded approval of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrinogen deficiency (AFD) by the U.S. Food and Drug Admini

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: